Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06893302 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Bone-Marrow Aspirate Injections in Knee Arthroscopy

Study acronym: BMA
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Apr 2028 → Apr 2029
See other at-risk trials from Hospital for Special Surgery, New York

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Apr 2028 to Apr 2029
    • Study completion pushed from Apr 2029 to Apr 2030
    • Start date changed from estimate of Jun 2026 to Feb 3, 2026
    v9
  2. Re-verified, no change to tracked fieldsv8
  3. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v7
  4. Eligibility criteria revised
    • Study description revised
    v6
  5. Start date: Jun 2025 to Jun 2026
    • Eligibility criteria shortened, about 6 words
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Start date: Apr 15, 2025 to Jun 2025v4
  2. Study title shortened, about 2 wordsv3
  3. Interventions: Arthroscopic Debridement Surgery (Procedure), Bone Marrow Aspirate (BMA) (Biological) to Arthroscopic Debridement Surgery (Procedure), Bone Marrow Aspirate (BMA) (Biological), Saline (Other)
    • Study description expanded, about 1 word
    • Study title shortened, about 1 word
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will examine whether using bone marrow aspirate (BMA) during knee arthroscopy surgery can improve patient outcomes. The investigators will enroll 50 patients who need knee arthroscopy surgery for meniscus injuries or cartilage damage. Like flipping a coin, patients will be randomly assigned to one of two groups of 25 patients each. One group will receive standard arthroscopic surgery plus an injection of bone marrow aspirate, while the other group will receive standard surgery plus a saline (salt water) injection. During surgery, for patients in the treatment group, approximately 4mL (less than one teaspoon) of bone marrow will be taken from their hip bone using a special needle system. A small amount (1mL) will be sent to the laboratory for testing. Patients will be followed for 12 months after surgery and will complete questionnaires about their pain levels and knee function at several time points: before surgery, 2 weeks, 6 weeks, 3 months, 6 months, and 12 months after surgery. These questionnaires will ask about pain, daily activities, and overall improvement.
Trial Details
NCT Number NCT06893302
Lead Sponsor Hospital for Special Surgery, New York
Conditions
(from sponsor)		 Chondral Lesion of the Knee, Meniscal Injuries, Cartilage Defects of the Knee, Osteoarthritis (OA) of the Knee
Related terms Osteoarthritis
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov